Patterns of outcome and toxicity after salvage prostatectomy, salvage cryosurgery and salvage brachytherapy for prostate cancer recurrences after radiation therapy: A multi-center experience and literature review

World Journal of Urology

Volumn 31, Issue 2, 2013, Pages 403-409

  Peters, Max ^a   Moman, Maaike R ^a   van der Poel, Henk G ^b   Vergunst, Henk ^c   de Jong, Igle Jan ^d   Vijverberg, Peter L M ^e   Battermann, Jan J ^a   Horenblas, Simon ^b   van Vulpen, Marco ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

^c CANISIUS WILHELMINA HOSPITAL   (Netherlands)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^e ST ANTONIUS HOSPITAL   (Netherlands)

Author keywords

Brachytherapy; Cryosurgery; Outcome; Prostate cancer; Prostatectomy; Salvage; Toxicity

Indexed keywords

EID: 84876435279     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-012-0928-8     Document Type: Article

References (31)

1. Agarwal PK, Sadetsky N, Konety BR, Resnick MI, Carroll PR (2008) Cancer of the Prostate Strategic Urological Research Endeavor (CaPSURE). Treatment failure after primary and salvage therapy for prostate cancer: likelihood, patterns of care, and outcomes. Cancer 112(2): 307-314.
2. Heidenreich A, Aus G, Bolla M, Joniau S, Matveev VB, Schmid HP et al (2008) EAU guidelines on prostate cancer. Eur Urol 53(1): 68-80.
3. Hinnen KA, Battermann JJ, van Roermund JG, Moerland MA, Jurgenliemk-Schulz IM, Frank SJ et al (2010) Long-term biochemical and survival outcome of 921 patients treated with I-125 permanent prostate brachytherapy. Int J Radiat Oncol Biol Phys 76(5): 1433-1438.
4. Kuban DA, Thames HD, Levy LB, Horwitz EM, Kupelian PA, Martinez AA et al (2003) Long-term multi-institutional analysis of stage T1-T2 prostate cancer treated with radiotherapy in the PSA era. Int J Radiat Oncol Biol Phys 57(4): 915-928.
5. Pound CR, Brawer MK, Partin AW (2001) Evaluation and treatment of men with biochemical prostate-specific antigen recurrence following definitive therapy for clinically localized prostate cancer. Rev Urol 3(2): 72-84.
6. Ahmed HU, Pendse D, Illing R, Allen C, van der Meulen JH, Emberton M (2007) Will focal therapy become a standard of care for men with localized prostate cancer? Nat Clin Pract Oncol 4(11): 632-642.
7. Pucar D, Hricak H, Shukla-Dave A, Kuroiwa K, Drobnjak M, Eastham J et al (2007) Clinically significant prostate cancer local recurrence after radiation therapy occurs at the site of primary tumor: magnetic resonance imaging and step-section pathology evidence. Int J Radiat Oncol Biol Phys 69(1): 62-69.
8. Kimura M, Mouraviev V, Tsivian M, Mayes JM, Satoh T, Polascik TJ (2010) Current salvage methods for recurrent prostate cancer after failure of primary radiotherapy. BJU Int 105(2): 191-201.
9. Nguyen PL, D'Amico AV, Lee AK, Suh WW (2007) Patient selection, cancer control, and complications after salvage local therapy for postradiation prostate-specific antigen failure: a systematic review of the literature. Cancer 110(7): 1417-1428.
10. Abuzallouf S, Dayes I, Lukka H (2004) Baseline staging of newly diagnosed prostate cancer: a summary of the literature. J Urol 171: 2122-2127.
11. van der Poel HG, Beetsma DB, van Boven H, Horenblas S (2007) Perineal salvage prostatectomy for radiation resistant prostate cancer. Eur Urol 51(6): 1565-1571 (discussion 1572).
12. Moman MR, van der Poel HG, Battermann JJ, Moerland MA, van Vulpen M (2010) Treatment outcome and toxicity after salvage 125-I implantation for prostate cancer recurrences after primary 125-I implantation and external beam radiotherapy. Brachytherapy 9(2): 119-125.
13. Ash D, Flynn A, Battermann J, de Reijke T, Lavagnini P, Blank L et al (2000) ESTRO/EAU/EORTC recommendations on permanent seed implantation for localized prostate cancer. Radiother Oncol 57(3): 315-321.
14. Battermann JJ (2000) I-125 implantation for localized prostate cancer: the Utrecht University experience. Radiother Oncol 57(3): 269-272.
15. Roach M III, Hanks H Jr, Thames G, Schellhammer P, Shipley WU, Sokol GH et al (2006) Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference. Int J Radiat Oncol Biol Phys 65(4): 965-974.
16. Trotti A, Colevas AD, Setser A, Rusch V, Jaques D, Budach V et al (2003) CTCAE, v3. 0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 13(3): 176-181.
17. Buyyounouski MK, Hanlon AL, Eisenberg DF, Horwitz EM, Feigenberg SJ, Uzzo RG et al (2005) Defining biochemical failure after radiotherapy with and without androgen deprivation for prostate cancer. Int J Radiat Oncol Biol Phys 63(5): 1455-1462.
18. Moman MR, van den Berg CA, Boeken Kruger AE, Battermann JJ, Moerland MA, van den Heide UA et al (2010) Focal salvage guided by T2-weighted and dynamic contrast-enhanced magnetic resonance imaging for prostate cancer recurrences. Int J Radiat Oncol Biol Phys 76(3): 741-746.
19. Haider MA, Chung P, Sweet J, Toi A, Jhaveri K, Menard C et al (2008) Dynamic contrast-enhanced magnetic resonance imaging for localization of recurrent prostate cancer after external beam radiotherapy. Int J Radiat Oncol Biol Phys 70(2): 425-430.
20. Ward JF, Sebo TJ, Blute ML, Zincke H (2005) Salvage surgery for radiorecurrent prostate cancer: contemporary outcomes. J Urol 173(4): 1156-1160.
21. Bianco FJ Jr, Scardino PT, Stephenson AJ, Diblasio CJ, Fearn PA, Eastham JA (2005) Long-term oncologic results of salvage radical prostatectomy for locally recurrent prostate cancer after radiotherapy. Int J Radiat Oncol Biol Phys 62(2): 448-453.
22. Sanderson KM, Penson DF, Cai J, Groshen S, Stein JP, Lieskovsky G et al (2006) Salvage radical prostatectomy: quality of life outcomes and long-term oncological control of radiorecurrent prostate cancer. J Urol 176(5): 2025-2031 (discussion 2031-2032).
23. Beyer DC (1999) Permanent brachytherapy as salvage treatment for recurrent prostate cancer. Urology 54(5): 880-883.
24. Grado GL, Collins JM, Kriegshauser JS, Balch CS, Grado MM, Swanson GP et al (1999) Salvage brachytherapy for localized prostate cancer after radiotherapy failure. Urology 53(1): 2-10.
25. Pisters LL, Rewcastle JC, Donnelly BJ, Lugnani FM, Katz AE, Jones JS (2008) Salvage prostate cryoablation: initial results from the cryo on-line data registry. J Urol 180(2): 559-563 (discussion 563-564).
26. Ng CK, Moussa M, Downey DB, Chin JL (2007) Salvage cryoablation of the prostate: follow-up and analysis of predictive factors for outcome. J Urol 178(4 Pt 1): 1253-1257 (discussion 1257).
27. Stephenson AJ, Scardino PT, Bianco FJ Jr, DiBlasio CJ, Fearn PA, Eastham JA (2004) Morbidity and functional outcomes of salvage radical prostatectomy for locally recurrent prostate cancer after radiation therapy. J Urol 172(6 Pt 1): 2239-2243.
28. Han KR, Cohen JK, Miller RJ, Pantuck AJ, Freitas DG, Cuevas CA et al (2003) Treatment of organ confined prostate cancer with third generation cryosurgery: preliminary multicenter experience. J Urol 170(4 Pt 1): 1126-1130.
29. Long JP, Fallick ML, LaRock DR, Rand W (1998) Preliminary outcomes following cryosurgical ablation of the prostate in patients with clinically localized prostate carcinoma. J Urol 159(2): 477-484.
30. Bahn DK, Lee F, Silverman P, Bahn E, Badalament R, Kumar A et al (2003) Salvage cryosurgery for recurrent prostate cancer after radiation therapy: a seven-year follow-up. Clin Prostate Cancer 2(2): 111-114.
31. Chin JL, Pautler SE, Mouraviev V, Touma N, Moore K, Downey DB (2001) Results of salvage cryoablation of the prostate after radiation: identifying predictors of treatment failure and complications. J Urol 165(6 Pt 1): 1937-1941 (discussion 1941-1942).